Apple Urges US Appeals Courtroom to Overturn ITC’s Apple Watch Import Ban Amidst Masimo Dispute

2 min read

Apple urged a U.S. appeals courtroom on Friday to overturn a U.S. commerce tribunal’s resolution to ban imports of some Apple Watches in a patent dispute with medical-monitoring know-how firm Masimo.

Apple advised the U.S. Courtroom of Appeals for the Federal Circuit that the U.S. Worldwide Commerce Fee’s resolution was based mostly on a “sequence of substantively faulty patent rulings,” and that Masimo failed to point out it had invested in making competing U.S. merchandise that may justify the order.

Representatives for Apple and Masimo didn’t instantly reply to requests for touch upon the submitting.

Irvine, California-based Masimo has accused Apple of hiring away its staff and stealing its pulse oximetry know-how after discussing a possible collaboration. Apple first launched pulse oximetry to its Sequence 6 Apple Watches in 2020.

Masimo satisfied the ITC on Dec. 26 to dam imports of Apple’s latest-edition Sequence 9 and Extremely 2 smartwatches after discovering that their know-how for studying blood-oxygen ranges infringed Masimo’s patents.

Apple briefly resumed gross sales of the watches the subsequent day after persuading the Federal Circuit to pause the ban. The appeals courtroom reinstated the ban in January, main Apple to take away pulse oximetry capabilities from watches bought in the course of the attraction, which Apple has mentioned might final at the least a 12 months.

U.S. Customs and Border Safety individually decided in January that redesigned variations of the watches didn’t violate Masimo’s rights and wouldn’t be not topic to the ban. Masimo mentioned in a courtroom submitting that the watches “definitively don’t comprise pulse oximetry performance.”

Apple advised the Federal Circuit on Friday that the ban couldn’t stand as a result of a Masimo wearable coated by the patents was “purely hypothetical” when it filed its ITC grievance in 2021.

The tech big additionally argued that Masimo’s patents had been invalid and that its watches didn’t infringe them.

© Thomson Reuters 2024


Affiliate hyperlinks could also be mechanically generated – see our ethics assertion for particulars.

You May Also Like

More From Author

+ There are no comments

Add yours